Dynavax Technologies Corporation (DVAX)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 12.70% | 27.08% | 33.36% | 42.89% | 45.31% | 33.68% | 37.75% | 30.53% | 36.61% | 64.04% | 46.77% | 26.76% | -93.27% | -74.81% | -152.84% | -167.85% | -216.50% | -305.17% | -444.22% | -468.91% |
| Operating profit margin | -15.75% | 9.57% | 19.82% | 33.93% | 39.22% | 40.77% | 37.61% | 29.19% | 30.90% | 16.55% | 7.45% | -17.49% | -152.44% | -216.43% | -359.03% | -400.02% | -561.87% | -775.67% | -1,136.62% | -1,380.59% |
| Pretax margin | -1.84% | 17.33% | 24.55% | 36.25% | 40.71% | 44.26% | 34.46% | 23.37% | 17.81% | -15.23% | -3.55% | -52.61% | -167.76% | -249.11% | -479.29% | -431.74% | -635.86% | -831.14% | -1,204.66% | -1,441.59% |
| Net profit margin | -2.72% | 16.92% | 24.13% | 35.98% | 40.55% | 44.03% | 34.25% | 23.20% | 17.63% | -15.23% | -3.55% | -52.61% | -167.77% | -249.13% | -479.31% | -431.75% | -635.86% | -831.14% | -1,204.66% | -1,441.59% |
Dynavax Technologies Corp.'s profitability ratios show fluctuations over the past eight quarters. The gross profit margin has been relatively stable, ranging from 61.79% to 78.40%. This indicates the company's ability to generate profits from its core operations.
However, the operating profit margin has been more volatile, with significant fluctuations from -16.37% to 40.93%. This suggests that Dynavax has experienced variability in its operating efficiency and control over costs during this period.
Similarly, the pretax and net profit margins have shown fluctuations, with both metrics peaking in Q4 2022 at 40.72% and 43.76%, respectively. Despite this, the company experienced a negative net profit margin in Q4 2023, indicating that expenses exceeded revenue in that period.
Overall, Dynavax Technologies Corp. should carefully monitor its operating expenses and strive for consistent profitability to ensure long-term financial health and sustainability.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -3.71% | 3.56% | 9.70% | 22.94% | 28.76% | 30.13% | 25.00% | 13.55% | 12.94% | 4.55% | 1.85% | -4.19% | -19.35% | -23.73% | -30.57% | -44.86% | -48.32% | -48.31% | -57.54% | -51.54% |
| Return on assets (ROA) | -0.64% | 6.28% | 11.82% | 24.33% | 29.74% | 32.54% | 22.77% | 10.77% | 7.38% | -4.19% | -0.88% | -12.60% | -21.30% | -27.32% | -40.81% | -48.42% | -54.68% | -51.76% | -60.99% | -53.81% |
| Return on total capital | 0.39% | 11.47% | 20.67% | 43.37% | 51.81% | 66.65% | 57.03% | 40.92% | 39.89% | -8.85% | -4.13% | -15.54% | -28.67% | -33.68% | -42.31% | -60.76% | -72.15% | -67.08% | -82.09% | -69.85% |
| Return on equity (ROE) | -1.03% | 10.10% | 19.17% | 41.86% | 50.46% | 64.97% | 55.10% | 37.80% | 34.50% | -57.02% | -6.84% | -61.90% | -128.20% | -139.33% | -230.54% | -1,061.64% | -1,840.77% | -397.93% | -1,538.36% | -369.83% |
Based on the profitability ratios for Dynavax Technologies Corp. over the mentioned quarters, we can observe fluctuations in the company's financial performance.
1. Operating return on assets (Operating ROA): This ratio measures the company's operating profitability relative to its total assets. The trend shows that Dynavax's operating ROA has been inconsistent, with a significant decrease from Q4 2022 to Q1 2023, followed by a gradual increase until Q3 2023. The most recent quarter, Q4 2023, saw a negative operating ROA, indicating a decline in operating profitability relative to the company's asset base.
2. Return on assets (ROA): This ratio evaluates the company's overall profitability by comparing its net income to total assets. Dynavax's ROA also experienced fluctuations over the quarters, with a peak in Q1 2023, followed by a decline in Q2 and Q3 2023. However, in Q4 2023, the ROA turned negative, suggesting that the company's profitability generated from its assets was insufficient to cover its expenses.
3. Return on total capital: This ratio assesses the company's profitability in relation to its total capital employed, including both equity and debt. There is a general trend of increasing return on total capital from Q1 2022 to Q4 2022, indicating efficient utilization of the company's total resources. However, there was a notable decrease in Q1 2023, followed by fluctuations in the subsequent quarters, with a negative return in Q4 2023, highlighting a concerning decline in profitability relative to the total capital employed.
4. Return on equity (ROE): This ratio measures the company's profitability from the perspective of its shareholders' equity. Dynavax's ROE displayed a similar trend to the return on total capital, with a steady increase from Q1 2022 to Q3 2022, followed by fluctuations in the following periods. Despite reaching a peak in Q4 2022, the ROE declined in the subsequent quarters, with a negative return in Q4 2023, indicating lower profitability generated from shareholders' equity.
Overall, the profitability ratios for Dynavax Technologies Corp. reveal a concerning trend of declining profitability and efficiency across various metrics, raising potential red flags about the company's financial performance and sustainability. Further analysis and investigation into the underlying reasons for these fluctuations are necessary to provide better insights into the company's financial health.